nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—CYP2C19—coronary artery disease	0.145	0.643	CbGaD
Enzalutamide—ALB—coronary artery disease	0.0805	0.357	CbGaD
Enzalutamide—CYP2C8—Fenofibrate—coronary artery disease	0.0162	0.0285	CbGbCtD
Enzalutamide—CYP2B6—Clopidogrel—coronary artery disease	0.0148	0.0261	CbGbCtD
Enzalutamide—CYP2C8—Gemfibrozil—coronary artery disease	0.013	0.0228	CbGbCtD
Enzalutamide—ALB—Pitavastatin—coronary artery disease	0.0127	0.0224	CbGbCtD
Enzalutamide—ALB—Valsartan—coronary artery disease	0.0124	0.0218	CbGbCtD
Enzalutamide—ABCB1—Ticagrelor—coronary artery disease	0.0123	0.0217	CbGbCtD
Enzalutamide—CYP3A5—Clopidogrel—coronary artery disease	0.0117	0.0206	CbGbCtD
Enzalutamide—CYP2C9—Fenofibrate—coronary artery disease	0.0113	0.0199	CbGbCtD
Enzalutamide—CYP2C8—Clopidogrel—coronary artery disease	0.0112	0.0198	CbGbCtD
Enzalutamide—CYP2C19—Gemfibrozil—coronary artery disease	0.0109	0.0191	CbGbCtD
Enzalutamide—CYP3A5—Eplerenone—coronary artery disease	0.0109	0.0191	CbGbCtD
Enzalutamide—CYP2C8—Pitavastatin—coronary artery disease	0.00982	0.0173	CbGbCtD
Enzalutamide—CYP2C19—Clopidogrel—coronary artery disease	0.00942	0.0166	CbGbCtD
Enzalutamide—ALB—Rosuvastatin—coronary artery disease	0.00936	0.0165	CbGbCtD
Enzalutamide—ALB—Acetylsalicylic acid—coronary artery disease	0.00913	0.0161	CbGbCtD
Enzalutamide—CYP2C9—Gemfibrozil—coronary artery disease	0.00903	0.0159	CbGbCtD
Enzalutamide—ALB—Captopril—coronary artery disease	0.00901	0.0159	CbGbCtD
Enzalutamide—CYP2B6—Simvastatin—coronary artery disease	0.00888	0.0157	CbGbCtD
Enzalutamide—CYP2C19—Telmisartan—coronary artery disease	0.00823	0.0145	CbGbCtD
Enzalutamide—CYP2B6—Atorvastatin—coronary artery disease	0.00792	0.014	CbGbCtD
Enzalutamide—CYP2C9—Clopidogrel—coronary artery disease	0.00783	0.0138	CbGbCtD
Enzalutamide—ABCB1—Perindopril—coronary artery disease	0.0076	0.0134	CbGbCtD
Enzalutamide—ABCB1—Clopidogrel—coronary artery disease	0.0076	0.0134	CbGbCtD
Enzalutamide—CYP3A5—Rosuvastatin—coronary artery disease	0.00753	0.0133	CbGbCtD
Enzalutamide—CYP3A4—Ticagrelor—coronary artery disease	0.00737	0.013	CbGbCtD
Enzalutamide—ALB—Furosemide—coronary artery disease	0.00724	0.0128	CbGbCtD
Enzalutamide—ALB—Losartan—coronary artery disease	0.0071	0.0125	CbGbCtD
Enzalutamide—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00705	0.0124	CbGbCtD
Enzalutamide—CYP3A5—Simvastatin—coronary artery disease	0.007	0.0123	CbGbCtD
Enzalutamide—CYP3A5—Lovastatin—coronary artery disease	0.00685	0.0121	CbGbCtD
Enzalutamide—CYP3A5—Pravastatin—coronary artery disease	0.00685	0.0121	CbGbCtD
Enzalutamide—CYP2C9—Pitavastatin—coronary artery disease	0.00685	0.0121	CbGbCtD
Enzalutamide—CYP2C8—Simvastatin—coronary artery disease	0.00673	0.0119	CbGbCtD
Enzalutamide—CYP2C9—Valsartan—coronary artery disease	0.00666	0.0117	CbGbCtD
Enzalutamide—ABCB1—Pitavastatin—coronary artery disease	0.00664	0.0117	CbGbCtD
Enzalutamide—ABCB1—Telmisartan—coronary artery disease	0.00664	0.0117	CbGbCtD
Enzalutamide—CYP2C19—Timolol—coronary artery disease	0.00664	0.0117	CbGbCtD
Enzalutamide—CYP2C8—Pravastatin—coronary artery disease	0.00658	0.0116	CbGbCtD
Enzalutamide—CYP2C8—Lovastatin—coronary artery disease	0.00658	0.0116	CbGbCtD
Enzalutamide—CYP3A4—Fenofibrate—coronary artery disease	0.00657	0.0116	CbGbCtD
Enzalutamide—ABCB1—Enalapril—coronary artery disease	0.0063	0.0111	CbGbCtD
Enzalutamide—ABCB1—Lisinopril—coronary artery disease	0.0063	0.0111	CbGbCtD
Enzalutamide—CYP3A5—Atorvastatin—coronary artery disease	0.00624	0.011	CbGbCtD
Enzalutamide—CYP2C19—Rosuvastatin—coronary artery disease	0.00607	0.0107	CbGbCtD
Enzalutamide—CYP2C8—Atorvastatin—coronary artery disease	0.006	0.0106	CbGbCtD
Enzalutamide—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00592	0.0104	CbGbCtD
Enzalutamide—CYP3A5—Losartan—coronary artery disease	0.0057	0.0101	CbGbCtD
Enzalutamide—CYP2C19—Simvastatin—coronary artery disease	0.00564	0.00995	CbGbCtD
Enzalutamide—CYP2C19—Lovastatin—coronary artery disease	0.00552	0.00973	CbGbCtD
Enzalutamide—CYP2C8—Losartan—coronary artery disease	0.00548	0.00966	CbGbCtD
Enzalutamide—CYP2D6—Niacin—coronary artery disease	0.00543	0.00957	CbGbCtD
Enzalutamide—ABCB1—Timolol—coronary artery disease	0.00536	0.00944	CbGbCtD
Enzalutamide—CYP3A4—Gemfibrozil—coronary artery disease	0.00525	0.00926	CbGbCtD
Enzalutamide—CYP2C9—Rosuvastatin—coronary artery disease	0.00505	0.00889	CbGbCtD
Enzalutamide—CYP2D6—Timolol—coronary artery disease	0.00505	0.00889	CbGbCtD
Enzalutamide—CYP2C19—Atorvastatin—coronary artery disease	0.00503	0.00886	CbGbCtD
Enzalutamide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00492	0.00867	CbGbCtD
Enzalutamide—ABCB1—Ezetimibe—coronary artery disease	0.0049	0.00863	CbGbCtD
Enzalutamide—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00477	0.00841	CbGbCtD
Enzalutamide—ABCB1—Captopril—coronary artery disease	0.00471	0.00831	CbGbCtD
Enzalutamide—CYP2C9—Simvastatin—coronary artery disease	0.00469	0.00827	CbGbCtD
Enzalutamide—CYP2C19—Losartan—coronary artery disease	0.0046	0.00811	CbGbCtD
Enzalutamide—CYP2C9—Pravastatin—coronary artery disease	0.00459	0.00809	CbGbCtD
Enzalutamide—CYP2C9—Lovastatin—coronary artery disease	0.00459	0.00809	CbGbCtD
Enzalutamide—CYP3A4—Clopidogrel—coronary artery disease	0.00455	0.00803	CbGbCtD
Enzalutamide—ABCB1—Simvastatin—coronary artery disease	0.00455	0.00802	CbGbCtD
Enzalutamide—ABCB1—Lovastatin—coronary artery disease	0.00446	0.00785	CbGbCtD
Enzalutamide—ABCB1—Pravastatin—coronary artery disease	0.00446	0.00785	CbGbCtD
Enzalutamide—CYP2D6—Captopril—coronary artery disease	0.00444	0.00783	CbGbCtD
Enzalutamide—CYP2D6—Simvastatin—coronary artery disease	0.00429	0.00756	CbGbCtD
Enzalutamide—CYP3A4—Eplerenone—coronary artery disease	0.00423	0.00746	CbGbCtD
Enzalutamide—CYP2D6—Pravastatin—coronary artery disease	0.0042	0.0074	CbGbCtD
Enzalutamide—CYP2D6—Lovastatin—coronary artery disease	0.0042	0.0074	CbGbCtD
Enzalutamide—CYP2C9—Atorvastatin—coronary artery disease	0.00418	0.00737	CbGbCtD
Enzalutamide—ABCB1—Atorvastatin—coronary artery disease	0.00406	0.00715	CbGbCtD
Enzalutamide—CYP2C9—Losartan—coronary artery disease	0.00382	0.00674	CbGbCtD
Enzalutamide—CYP2D6—Atorvastatin—coronary artery disease	0.00382	0.00674	CbGbCtD
Enzalutamide—CYP3A4—Enalapril—coronary artery disease	0.00377	0.00665	CbGbCtD
Enzalutamide—ABCB1—Losartan—coronary artery disease	0.00371	0.00654	CbGbCtD
Enzalutamide—CYP3A4—Ezetimibe—coronary artery disease	0.00293	0.00517	CbGbCtD
Enzalutamide—CYP3A4—Rosuvastatin—coronary artery disease	0.00293	0.00517	CbGbCtD
Enzalutamide—CYP3A4—Simvastatin—coronary artery disease	0.00273	0.00481	CbGbCtD
Enzalutamide—CYP3A4—Lovastatin—coronary artery disease	0.00267	0.00471	CbGbCtD
Enzalutamide—CYP3A4—Pravastatin—coronary artery disease	0.00267	0.00471	CbGbCtD
Enzalutamide—CYP3A4—Atorvastatin—coronary artery disease	0.00243	0.00429	CbGbCtD
Enzalutamide—CYP3A4—Losartan—coronary artery disease	0.00222	0.00392	CbGbCtD
Enzalutamide—CYP2C9—cardial valve—coronary artery disease	0.00127	0.461	CbGeAlD
Enzalutamide—Bicalutamide—CYP2C19—coronary artery disease	0.00116	0.608	CrCbGaD
Enzalutamide—Nilutamide—CYP2C19—coronary artery disease	0.000746	0.392	CrCbGaD
Enzalutamide—AR—cardiac ventricle—coronary artery disease	0.000149	0.054	CbGeAlD
Enzalutamide—AR—myocardium—coronary artery disease	0.00014	0.0508	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.00013	0.000941	CcSEcCtD
Enzalutamide—Leukopenia—Perindopril—coronary artery disease	0.00013	0.000941	CcSEcCtD
Enzalutamide—Pruritus—Rosuvastatin—coronary artery disease	0.00013	0.00094	CcSEcCtD
Enzalutamide—Skin disorder—Niacin—coronary artery disease	0.00013	0.00094	CcSEcCtD
Enzalutamide—Haematuria—Lisinopril—coronary artery disease	0.000129	0.000935	CcSEcCtD
Enzalutamide—Oedema peripheral—Timolol—coronary artery disease	0.000129	0.000935	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000129	0.000933	CcSEcCtD
Enzalutamide—Connective tissue disorder—Timolol—coronary artery disease	0.000129	0.000933	CcSEcCtD
Enzalutamide—Thrombocytopenia—Pravastatin—coronary artery disease	0.000129	0.000933	CcSEcCtD
Enzalutamide—Fatigue—Eplerenone—coronary artery disease	0.000129	0.000932	CcSEcCtD
Enzalutamide—Epistaxis—Lisinopril—coronary artery disease	0.000128	0.000925	CcSEcCtD
Enzalutamide—Headache—Ticagrelor—coronary artery disease	0.000128	0.000925	CcSEcCtD
Enzalutamide—Arthralgia—Captopril—coronary artery disease	0.000127	0.000922	CcSEcCtD
Enzalutamide—Sinusitis—Lisinopril—coronary artery disease	0.000127	0.00092	CcSEcCtD
Enzalutamide—Infection—Trandolapril—coronary artery disease	0.000127	0.000919	CcSEcCtD
Enzalutamide—Vertigo—Furosemide—coronary artery disease	0.000127	0.000918	CcSEcCtD
Enzalutamide—Leukopenia—Furosemide—coronary artery disease	0.000126	0.000915	CcSEcCtD
Enzalutamide—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000126	0.000913	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000126	0.00091	CcSEcCtD
Enzalutamide—Diarrhoea—Rosuvastatin—coronary artery disease	0.000126	0.000909	CcSEcCtD
Enzalutamide—Fatigue—Simvastatin—coronary artery disease	0.000126	0.000908	CcSEcCtD
Enzalutamide—Hypertension—Perindopril—coronary artery disease	0.000125	0.000907	CcSEcCtD
Enzalutamide—Nervous system disorder—Trandolapril—coronary artery disease	0.000125	0.000907	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Valsartan—coronary artery disease	0.000125	0.000906	CcSEcCtD
Enzalutamide—Thrombocytopenia—Trandolapril—coronary artery disease	0.000125	0.000906	CcSEcCtD
Enzalutamide—Infection—Telmisartan—coronary artery disease	0.000125	0.000903	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Olmesartan—coronary artery disease	0.000125	0.000902	CcSEcCtD
Enzalutamide—Thrombocytopenia—Enalapril—coronary artery disease	0.000125	0.000902	CcSEcCtD
Enzalutamide—Insomnia—Valsartan—coronary artery disease	0.000124	0.0009	CcSEcCtD
Enzalutamide—Skin disorder—Trandolapril—coronary artery disease	0.000124	0.000898	CcSEcCtD
Enzalutamide—Insomnia—Olmesartan—coronary artery disease	0.000124	0.000896	CcSEcCtD
Enzalutamide—Arthralgia—Perindopril—coronary artery disease	0.000124	0.000895	CcSEcCtD
Enzalutamide—Paraesthesia—Valsartan—coronary artery disease	0.000123	0.000893	CcSEcCtD
Enzalutamide—Anxiety—Perindopril—coronary artery disease	0.000123	0.000892	CcSEcCtD
Enzalutamide—Nervous system disorder—Telmisartan—coronary artery disease	0.000123	0.000891	CcSEcCtD
Enzalutamide—Thrombocytopenia—Telmisartan—coronary artery disease	0.000123	0.00089	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000123	0.000889	CcSEcCtD
Enzalutamide—Vertigo—Losartan—coronary artery disease	0.000122	0.000886	CcSEcCtD
Enzalutamide—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000122	0.000883	CcSEcCtD
Enzalutamide—Rhinitis—Lisinopril—coronary artery disease	0.000122	0.000883	CcSEcCtD
Enzalutamide—Skin disorder—Telmisartan—coronary artery disease	0.000122	0.000883	CcSEcCtD
Enzalutamide—Leukopenia—Losartan—coronary artery disease	0.000122	0.000882	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Niacin—coronary artery disease	0.000122	0.000881	CcSEcCtD
Enzalutamide—Dizziness—Rosuvastatin—coronary artery disease	0.000121	0.000879	CcSEcCtD
Enzalutamide—Insomnia—Niacin—coronary artery disease	0.000121	0.000875	CcSEcCtD
Enzalutamide—Pharyngitis—Lisinopril—coronary artery disease	0.000121	0.000874	CcSEcCtD
Enzalutamide—Urinary tract disorder—Lisinopril—coronary artery disease	0.00012	0.00087	CcSEcCtD
Enzalutamide—Paraesthesia—Niacin—coronary artery disease	0.00012	0.000869	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Pravastatin—coronary artery disease	0.00012	0.000868	CcSEcCtD
Enzalutamide—Oedema peripheral—Lisinopril—coronary artery disease	0.00012	0.000868	CcSEcCtD
Enzalutamide—Thrombocytopenia—Captopril—coronary artery disease	0.00012	0.000865	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000119	0.000864	CcSEcCtD
Enzalutamide—Urethral disorder—Lisinopril—coronary artery disease	0.000119	0.000863	CcSEcCtD
Enzalutamide—Insomnia—Pravastatin—coronary artery disease	0.000119	0.000861	CcSEcCtD
Enzalutamide—Angiopathy—Timolol—coronary artery disease	0.000119	0.000861	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000119	0.000859	CcSEcCtD
Enzalutamide—Fatigue—Valsartan—coronary artery disease	0.000119	0.000858	CcSEcCtD
Enzalutamide—Paraesthesia—Pravastatin—coronary artery disease	0.000118	0.000855	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000118	0.000855	CcSEcCtD
Enzalutamide—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000118	0.000854	CcSEcCtD
Enzalutamide—Fatigue—Olmesartan—coronary artery disease	0.000118	0.000854	CcSEcCtD
Enzalutamide—Mental disorder—Ramipril—coronary artery disease	0.000118	0.000851	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000116	0.000843	CcSEcCtD
Enzalutamide—Nervous system disorder—Perindopril—coronary artery disease	0.000116	0.000841	CcSEcCtD
Enzalutamide—Thrombocytopenia—Perindopril—coronary artery disease	0.000116	0.00084	CcSEcCtD
Enzalutamide—Arthralgia—Losartan—coronary artery disease	0.000116	0.000839	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000116	0.000839	CcSEcCtD
Enzalutamide—Insomnia—Trandolapril—coronary artery disease	0.000116	0.000837	CcSEcCtD
Enzalutamide—Anxiety—Losartan—coronary artery disease	0.000116	0.000836	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Niacin—coronary artery disease	0.000115	0.000835	CcSEcCtD
Enzalutamide—Skin disorder—Perindopril—coronary artery disease	0.000115	0.000833	CcSEcCtD
Enzalutamide—Insomnia—Enalapril—coronary artery disease	0.000115	0.000833	CcSEcCtD
Enzalutamide—Headache—Rosuvastatin—coronary artery disease	0.000115	0.000833	CcSEcCtD
Enzalutamide—Mental disorder—Timolol—coronary artery disease	0.000115	0.000832	CcSEcCtD
Enzalutamide—Paraesthesia—Trandolapril—coronary artery disease	0.000115	0.000831	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000114	0.000828	CcSEcCtD
Enzalutamide—Asthenia—Fenofibrate—coronary artery disease	0.000114	0.000828	CcSEcCtD
Enzalutamide—Paraesthesia—Enalapril—coronary artery disease	0.000114	0.000827	CcSEcCtD
Enzalutamide—Insomnia—Telmisartan—coronary artery disease	0.000114	0.000822	CcSEcCtD
Enzalutamide—Fatigue—Pravastatin—coronary artery disease	0.000113	0.000821	CcSEcCtD
Enzalutamide—Nervous system disorder—Furosemide—coronary artery disease	0.000113	0.000818	CcSEcCtD
Enzalutamide—Thrombocytopenia—Furosemide—coronary artery disease	0.000113	0.000817	CcSEcCtD
Enzalutamide—ALB—heart—coronary artery disease	0.000113	0.0408	CbGeAlD
Enzalutamide—Pruritus—Fenofibrate—coronary artery disease	0.000113	0.000816	CcSEcCtD
Enzalutamide—Paraesthesia—Telmisartan—coronary artery disease	0.000113	0.000816	CcSEcCtD
Enzalutamide—Asthenia—Clopidogrel—coronary artery disease	0.000112	0.000813	CcSEcCtD
Enzalutamide—Skin disorder—Furosemide—coronary artery disease	0.000112	0.00081	CcSEcCtD
Enzalutamide—Asthenia—Lovastatin—coronary artery disease	0.000112	0.000808	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000111	0.000805	CcSEcCtD
Enzalutamide—Pruritus—Clopidogrel—coronary artery disease	0.000111	0.000802	CcSEcCtD
Enzalutamide—Infection—Losartan—coronary artery disease	0.00011	0.000799	CcSEcCtD
Enzalutamide—Insomnia—Captopril—coronary artery disease	0.00011	0.000799	CcSEcCtD
Enzalutamide—Angiopathy—Lisinopril—coronary artery disease	0.00011	0.000799	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.00011	0.000799	CcSEcCtD
Enzalutamide—Fatigue—Trandolapril—coronary artery disease	0.00011	0.000797	CcSEcCtD
Enzalutamide—Pruritus—Lovastatin—coronary artery disease	0.00011	0.000797	CcSEcCtD
Enzalutamide—Fatigue—Enalapril—coronary artery disease	0.00011	0.000794	CcSEcCtD
Enzalutamide—Paraesthesia—Captopril—coronary artery disease	0.00011	0.000793	CcSEcCtD
Enzalutamide—Asthenia—Ezetimibe—coronary artery disease	0.00011	0.000793	CcSEcCtD
Enzalutamide—Diarrhoea—Fenofibrate—coronary artery disease	0.000109	0.000789	CcSEcCtD
Enzalutamide—Nervous system disorder—Losartan—coronary artery disease	0.000109	0.000789	CcSEcCtD
Enzalutamide—Thrombocytopenia—Losartan—coronary artery disease	0.000109	0.000788	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000108	0.000784	CcSEcCtD
Enzalutamide—Fatigue—Telmisartan—coronary artery disease	0.000108	0.000783	CcSEcCtD
Enzalutamide—Pruritus—Ezetimibe—coronary artery disease	0.000108	0.000782	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000108	0.000782	CcSEcCtD
Enzalutamide—Insomnia—Perindopril—coronary artery disease	0.000107	0.000776	CcSEcCtD
Enzalutamide—Diarrhoea—Clopidogrel—coronary artery disease	0.000107	0.000776	CcSEcCtD
Enzalutamide—Asthenia—Eplerenone—coronary artery disease	0.000107	0.000776	CcSEcCtD
Enzalutamide—Mental disorder—Lisinopril—coronary artery disease	0.000107	0.000772	CcSEcCtD
Enzalutamide—Diarrhoea—Lovastatin—coronary artery disease	0.000106	0.000771	CcSEcCtD
Enzalutamide—Paraesthesia—Perindopril—coronary artery disease	0.000106	0.00077	CcSEcCtD
Enzalutamide—Pruritus—Eplerenone—coronary artery disease	0.000106	0.000765	CcSEcCtD
Enzalutamide—Dizziness—Fenofibrate—coronary artery disease	0.000105	0.000763	CcSEcCtD
Enzalutamide—Fatigue—Captopril—coronary artery disease	0.000105	0.000762	CcSEcCtD
Enzalutamide—Vertigo—Ramipril—coronary artery disease	0.000105	0.00076	CcSEcCtD
Enzalutamide—Leukopenia—Ramipril—coronary artery disease	0.000105	0.000757	CcSEcCtD
Enzalutamide—Asthenia—Simvastatin—coronary artery disease	0.000104	0.000756	CcSEcCtD
Enzalutamide—Diarrhoea—Ezetimibe—coronary artery disease	0.000104	0.000756	CcSEcCtD
Enzalutamide—Dizziness—Clopidogrel—coronary artery disease	0.000104	0.00075	CcSEcCtD
Enzalutamide—Paraesthesia—Furosemide—coronary artery disease	0.000103	0.000749	CcSEcCtD
Enzalutamide—Pruritus—Simvastatin—coronary artery disease	0.000103	0.000745	CcSEcCtD
Enzalutamide—Dizziness—Lovastatin—coronary artery disease	0.000103	0.000745	CcSEcCtD
Enzalutamide—Vertigo—Timolol—coronary artery disease	0.000103	0.000743	CcSEcCtD
Enzalutamide—Back pain—Lisinopril—coronary artery disease	0.000102	0.000742	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000102	0.000741	CcSEcCtD
Enzalutamide—Diarrhoea—Eplerenone—coronary artery disease	0.000102	0.00074	CcSEcCtD
Enzalutamide—Fatigue—Perindopril—coronary artery disease	0.000102	0.00074	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000101	0.000733	CcSEcCtD
Enzalutamide—Convulsion—Ramipril—coronary artery disease	0.000101	0.000732	CcSEcCtD
Enzalutamide—Dizziness—Ezetimibe—coronary artery disease	0.000101	0.000731	CcSEcCtD
Enzalutamide—Insomnia—Losartan—coronary artery disease	0.000101	0.000728	CcSEcCtD
Enzalutamide—Headache—Fenofibrate—coronary artery disease	9.99e-05	0.000723	CcSEcCtD
Enzalutamide—Paraesthesia—Losartan—coronary artery disease	9.98e-05	0.000723	CcSEcCtD
Enzalutamide—Diarrhoea—Simvastatin—coronary artery disease	9.96e-05	0.000721	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Furosemide—coronary artery disease	9.95e-05	0.00072	CcSEcCtD
Enzalutamide—Arthralgia—Ramipril—coronary artery disease	9.95e-05	0.00072	CcSEcCtD
Enzalutamide—Fatigue—Furosemide—coronary artery disease	9.94e-05	0.000719	CcSEcCtD
Enzalutamide—Anxiety—Ramipril—coronary artery disease	9.91e-05	0.000717	CcSEcCtD
Enzalutamide—Dizziness—Eplerenone—coronary artery disease	9.88e-05	0.000715	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.88e-05	0.000715	CcSEcCtD
Enzalutamide—Asthenia—Valsartan—coronary artery disease	9.86e-05	0.000714	CcSEcCtD
Enzalutamide—Hypertension—Timolol—coronary artery disease	9.86e-05	0.000714	CcSEcCtD
Enzalutamide—Asthenia—Olmesartan—coronary artery disease	9.82e-05	0.00071	CcSEcCtD
Enzalutamide—Headache—Clopidogrel—coronary artery disease	9.82e-05	0.00071	CcSEcCtD
Enzalutamide—AR—heart—coronary artery disease	9.81e-05	0.0354	CbGeAlD
Enzalutamide—Headache—Lovastatin—coronary artery disease	9.75e-05	0.000706	CcSEcCtD
Enzalutamide—Pruritus—Valsartan—coronary artery disease	9.73e-05	0.000704	CcSEcCtD
Enzalutamide—Arthralgia—Timolol—coronary artery disease	9.72e-05	0.000704	CcSEcCtD
Enzalutamide—Anxiety—Timolol—coronary artery disease	9.69e-05	0.000701	CcSEcCtD
Enzalutamide—Pruritus—Olmesartan—coronary artery disease	9.68e-05	0.0007	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.66e-05	0.000699	CcSEcCtD
Enzalutamide—Dizziness—Simvastatin—coronary artery disease	9.63e-05	0.000697	CcSEcCtD
Enzalutamide—Asthenia—Niacin—coronary artery disease	9.59e-05	0.000694	CcSEcCtD
Enzalutamide—Fatigue—Losartan—coronary artery disease	9.59e-05	0.000694	CcSEcCtD
Enzalutamide—Headache—Ezetimibe—coronary artery disease	9.56e-05	0.000692	CcSEcCtD
Enzalutamide—Vertigo—Lisinopril—coronary artery disease	9.52e-05	0.000689	CcSEcCtD
Enzalutamide—Leukopenia—Lisinopril—coronary artery disease	9.48e-05	0.000686	CcSEcCtD
Enzalutamide—Pruritus—Niacin—coronary artery disease	9.46e-05	0.000684	CcSEcCtD
Enzalutamide—Asthenia—Pravastatin—coronary artery disease	9.44e-05	0.000683	CcSEcCtD
Enzalutamide—Diarrhoea—Valsartan—coronary artery disease	9.41e-05	0.000681	CcSEcCtD
Enzalutamide—Diarrhoea—Olmesartan—coronary artery disease	9.36e-05	0.000677	CcSEcCtD
Enzalutamide—Headache—Eplerenone—coronary artery disease	9.36e-05	0.000677	CcSEcCtD
Enzalutamide—Nervous system disorder—Ramipril—coronary artery disease	9.35e-05	0.000677	CcSEcCtD
Enzalutamide—Thrombocytopenia—Ramipril—coronary artery disease	9.34e-05	0.000676	CcSEcCtD
Enzalutamide—Pruritus—Pravastatin—coronary artery disease	9.31e-05	0.000674	CcSEcCtD
Enzalutamide—Skin disorder—Ramipril—coronary artery disease	9.26e-05	0.00067	CcSEcCtD
Enzalutamide—Infection—Timolol—coronary artery disease	9.26e-05	0.00067	CcSEcCtD
Enzalutamide—AR—cardiovascular system—coronary artery disease	9.25e-05	0.0334	CbGeAlD
Enzalutamide—Asthenia—Trandolapril—coronary artery disease	9.17e-05	0.000664	CcSEcCtD
Enzalutamide—Diarrhoea—Niacin—coronary artery disease	9.15e-05	0.000662	CcSEcCtD
Enzalutamide—Nervous system disorder—Timolol—coronary artery disease	9.14e-05	0.000661	CcSEcCtD
Enzalutamide—Asthenia—Enalapril—coronary artery disease	9.13e-05	0.000661	CcSEcCtD
Enzalutamide—Headache—Simvastatin—coronary artery disease	9.12e-05	0.00066	CcSEcCtD
Enzalutamide—Dizziness—Valsartan—coronary artery disease	9.09e-05	0.000658	CcSEcCtD
Enzalutamide—Skin disorder—Timolol—coronary artery disease	9.05e-05	0.000655	CcSEcCtD
Enzalutamide—Dizziness—Olmesartan—coronary artery disease	9.05e-05	0.000655	CcSEcCtD
Enzalutamide—Pruritus—Trandolapril—coronary artery disease	9.04e-05	0.000654	CcSEcCtD
Enzalutamide—Arthralgia—Lisinopril—coronary artery disease	9.02e-05	0.000653	CcSEcCtD
Enzalutamide—Asthenia—Telmisartan—coronary artery disease	9.01e-05	0.000652	CcSEcCtD
Enzalutamide—Pruritus—Enalapril—coronary artery disease	9.01e-05	0.000652	CcSEcCtD
Enzalutamide—Diarrhoea—Pravastatin—coronary artery disease	9.01e-05	0.000652	CcSEcCtD
Enzalutamide—Anxiety—Lisinopril—coronary artery disease	8.99e-05	0.00065	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.96e-05	0.000648	CcSEcCtD
Enzalutamide—Pruritus—Telmisartan—coronary artery disease	8.88e-05	0.000643	CcSEcCtD
Enzalutamide—Dizziness—Niacin—coronary artery disease	8.84e-05	0.00064	CcSEcCtD
Enzalutamide—Asthenia—Captopril—coronary artery disease	8.76e-05	0.000634	CcSEcCtD
Enzalutamide—Diarrhoea—Trandolapril—coronary artery disease	8.75e-05	0.000633	CcSEcCtD
Enzalutamide—Diarrhoea—Enalapril—coronary artery disease	8.71e-05	0.00063	CcSEcCtD
Enzalutamide—Dizziness—Pravastatin—coronary artery disease	8.7e-05	0.00063	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.69e-05	0.000629	CcSEcCtD
Enzalutamide—Pruritus—Captopril—coronary artery disease	8.64e-05	0.000625	CcSEcCtD
Enzalutamide—Insomnia—Ramipril—coronary artery disease	8.62e-05	0.000624	CcSEcCtD
Enzalutamide—Headache—Valsartan—coronary artery disease	8.61e-05	0.000623	CcSEcCtD
Enzalutamide—Diarrhoea—Telmisartan—coronary artery disease	8.59e-05	0.000622	CcSEcCtD
Enzalutamide—Infection—Lisinopril—coronary artery disease	8.59e-05	0.000622	CcSEcCtD
Enzalutamide—Headache—Olmesartan—coronary artery disease	8.57e-05	0.00062	CcSEcCtD
Enzalutamide—Paraesthesia—Ramipril—coronary artery disease	8.56e-05	0.00062	CcSEcCtD
Enzalutamide—Asthenia—Perindopril—coronary artery disease	8.51e-05	0.000615	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Timolol—coronary artery disease	8.49e-05	0.000615	CcSEcCtD
Enzalutamide—Thrombocytopenia—Lisinopril—coronary artery disease	8.47e-05	0.000613	CcSEcCtD
Enzalutamide—Dizziness—Trandolapril—coronary artery disease	8.45e-05	0.000612	CcSEcCtD
Enzalutamide—Insomnia—Timolol—coronary artery disease	8.43e-05	0.00061	CcSEcCtD
Enzalutamide—Dizziness—Enalapril—coronary artery disease	8.42e-05	0.000609	CcSEcCtD
Enzalutamide—Skin disorder—Lisinopril—coronary artery disease	8.4e-05	0.000608	CcSEcCtD
Enzalutamide—Pruritus—Perindopril—coronary artery disease	8.39e-05	0.000607	CcSEcCtD
Enzalutamide—AR—cardiac atrium—coronary artery disease	8.39e-05	0.0303	CbGeAlD
Enzalutamide—Headache—Niacin—coronary artery disease	8.37e-05	0.000606	CcSEcCtD
Enzalutamide—Paraesthesia—Timolol—coronary artery disease	8.37e-05	0.000606	CcSEcCtD
Enzalutamide—Diarrhoea—Captopril—coronary artery disease	8.35e-05	0.000605	CcSEcCtD
Enzalutamide—Dizziness—Telmisartan—coronary artery disease	8.3e-05	0.000601	CcSEcCtD
Enzalutamide—Asthenia—Furosemide—coronary artery disease	8.27e-05	0.000598	CcSEcCtD
Enzalutamide—Headache—Pravastatin—coronary artery disease	8.25e-05	0.000597	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Ramipril—coronary artery disease	8.23e-05	0.000596	CcSEcCtD
Enzalutamide—Fatigue—Ramipril—coronary artery disease	8.22e-05	0.000595	CcSEcCtD
Enzalutamide—Pruritus—Furosemide—coronary artery disease	8.15e-05	0.00059	CcSEcCtD
Enzalutamide—Diarrhoea—Perindopril—coronary artery disease	8.11e-05	0.000587	CcSEcCtD
Enzalutamide—Dizziness—Captopril—coronary artery disease	8.07e-05	0.000584	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Timolol—coronary artery disease	8.05e-05	0.000582	CcSEcCtD
Enzalutamide—Fatigue—Timolol—coronary artery disease	8.04e-05	0.000582	CcSEcCtD
Enzalutamide—Headache—Trandolapril—coronary artery disease	8.01e-05	0.000579	CcSEcCtD
Enzalutamide—Asthenia—Losartan—coronary artery disease	7.98e-05	0.000577	CcSEcCtD
Enzalutamide—Headache—Enalapril—coronary artery disease	7.97e-05	0.000577	CcSEcCtD
Enzalutamide—Diarrhoea—Furosemide—coronary artery disease	7.88e-05	0.000571	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.88e-05	0.00057	CcSEcCtD
Enzalutamide—Pruritus—Losartan—coronary artery disease	7.87e-05	0.000569	CcSEcCtD
Enzalutamide—Headache—Telmisartan—coronary artery disease	7.87e-05	0.000569	CcSEcCtD
Enzalutamide—Dizziness—Perindopril—coronary artery disease	7.84e-05	0.000567	CcSEcCtD
Enzalutamide—Insomnia—Lisinopril—coronary artery disease	7.82e-05	0.000566	CcSEcCtD
Enzalutamide—Paraesthesia—Lisinopril—coronary artery disease	7.76e-05	0.000562	CcSEcCtD
Enzalutamide—Headache—Captopril—coronary artery disease	7.65e-05	0.000554	CcSEcCtD
Enzalutamide—Dizziness—Furosemide—coronary artery disease	7.62e-05	0.000551	CcSEcCtD
Enzalutamide—Diarrhoea—Losartan—coronary artery disease	7.61e-05	0.000551	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.47e-05	0.00054	CcSEcCtD
Enzalutamide—Fatigue—Lisinopril—coronary artery disease	7.45e-05	0.000539	CcSEcCtD
Enzalutamide—Headache—Perindopril—coronary artery disease	7.43e-05	0.000537	CcSEcCtD
Enzalutamide—Dizziness—Losartan—coronary artery disease	7.35e-05	0.000532	CcSEcCtD
Enzalutamide—AR—blood—coronary artery disease	7.32e-05	0.0264	CbGeAlD
Enzalutamide—Headache—Furosemide—coronary artery disease	7.22e-05	0.000522	CcSEcCtD
Enzalutamide—CYP2B6—heart—coronary artery disease	7.11e-05	0.0257	CbGeAlD
Enzalutamide—CYP2C9—heart—coronary artery disease	7.04e-05	0.0255	CbGeAlD
Enzalutamide—Headache—Losartan—coronary artery disease	6.97e-05	0.000504	CcSEcCtD
Enzalutamide—Asthenia—Ramipril—coronary artery disease	6.84e-05	0.000495	CcSEcCtD
Enzalutamide—CYP2C19—blood—coronary artery disease	6.78e-05	0.0245	CbGeAlD
Enzalutamide—Pruritus—Ramipril—coronary artery disease	6.75e-05	0.000488	CcSEcCtD
Enzalutamide—CYP2B6—cardiovascular system—coronary artery disease	6.71e-05	0.0243	CbGeAlD
Enzalutamide—Asthenia—Timolol—coronary artery disease	6.69e-05	0.000484	CcSEcCtD
Enzalutamide—CYP2C9—cardiovascular system—coronary artery disease	6.65e-05	0.024	CbGeAlD
Enzalutamide—Pruritus—Timolol—coronary artery disease	6.59e-05	0.000477	CcSEcCtD
Enzalutamide—Diarrhoea—Ramipril—coronary artery disease	6.52e-05	0.000472	CcSEcCtD
Enzalutamide—Diarrhoea—Timolol—coronary artery disease	6.38e-05	0.000461	CcSEcCtD
Enzalutamide—Dizziness—Ramipril—coronary artery disease	6.3e-05	0.000456	CcSEcCtD
Enzalutamide—Asthenia—Lisinopril—coronary artery disease	6.2e-05	0.000449	CcSEcCtD
Enzalutamide—Dizziness—Timolol—coronary artery disease	6.16e-05	0.000446	CcSEcCtD
Enzalutamide—Pruritus—Lisinopril—coronary artery disease	6.12e-05	0.000443	CcSEcCtD
Enzalutamide—Headache—Ramipril—coronary artery disease	5.97e-05	0.000432	CcSEcCtD
Enzalutamide—CYP2C8—blood—coronary artery disease	5.92e-05	0.0214	CbGeAlD
Enzalutamide—Diarrhoea—Lisinopril—coronary artery disease	5.92e-05	0.000428	CcSEcCtD
Enzalutamide—Headache—Timolol—coronary artery disease	5.84e-05	0.000423	CcSEcCtD
Enzalutamide—Dizziness—Lisinopril—coronary artery disease	5.72e-05	0.000414	CcSEcCtD
Enzalutamide—Headache—Lisinopril—coronary artery disease	5.42e-05	0.000392	CcSEcCtD
Enzalutamide—CYP3A5—blood—coronary artery disease	5.34e-05	0.0193	CbGeAlD
Enzalutamide—CYP2B6—blood—coronary artery disease	5.31e-05	0.0192	CbGeAlD
Enzalutamide—CYP2C9—blood—coronary artery disease	5.26e-05	0.019	CbGeAlD
Enzalutamide—CYP3A4—blood—coronary artery disease	4.01e-05	0.0145	CbGeAlD
Enzalutamide—CYP2D6—blood—coronary artery disease	3.94e-05	0.0143	CbGeAlD
Enzalutamide—ABCB1—heart—coronary artery disease	3.8e-05	0.0137	CbGeAlD
Enzalutamide—ABCB1—cardiovascular system—coronary artery disease	3.59e-05	0.013	CbGeAlD
Enzalutamide—ABCB1—blood—coronary artery disease	2.84e-05	0.0103	CbGeAlD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.67e-06	5.73e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CTGF—coronary artery disease	3.63e-06	5.66e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—LPL—coronary artery disease	3.62e-06	5.64e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—coronary artery disease	3.6e-06	5.62e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CTGF—coronary artery disease	3.6e-06	5.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.59e-06	5.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GOT2—coronary artery disease	3.59e-06	5.61e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PLCB1—coronary artery disease	3.59e-06	5.61e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.56e-06	5.56e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GOT2—coronary artery disease	3.56e-06	5.56e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX2—coronary artery disease	3.55e-06	5.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.55e-06	5.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA2—coronary artery disease	3.55e-06	5.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—LPL—coronary artery disease	3.54e-06	5.51e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GPX1—coronary artery disease	3.53e-06	5.5e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.53e-06	5.5e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.51e-06	5.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX4—coronary artery disease	3.51e-06	5.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.51e-06	5.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HK1—coronary artery disease	3.51e-06	5.48e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PLCB1—coronary artery disease	3.51e-06	5.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCA1—coronary artery disease	3.48e-06	5.43e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HADHA—coronary artery disease	3.47e-06	5.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GPX1—coronary artery disease	3.45e-06	5.38e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CD36—coronary artery disease	3.44e-06	5.36e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.43e-06	5.35e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ABCA1—coronary artery disease	3.4e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—coronary artery disease	3.4e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—coronary artery disease	3.4e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPP2CA—coronary artery disease	3.39e-06	5.29e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPA—coronary artery disease	3.39e-06	5.29e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—coronary artery disease	3.38e-06	5.27e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GOT1—coronary artery disease	3.37e-06	5.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GGT1—coronary artery disease	3.37e-06	5.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	3.36e-06	5.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CD36—coronary artery disease	3.36e-06	5.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—coronary artery disease	3.35e-06	5.22e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARGC1A—coronary artery disease	3.34e-06	5.22e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—coronary artery disease	3.33e-06	5.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.32e-06	5.17e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.31e-06	5.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAT—coronary artery disease	3.3e-06	5.15e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GGT1—coronary artery disease	3.29e-06	5.14e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GOT1—coronary artery disease	3.29e-06	5.14e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAT—coronary artery disease	3.29e-06	5.12e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.28e-06	5.12e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.28e-06	5.11e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—coronary artery disease	3.26e-06	5.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA5—coronary artery disease	3.25e-06	5.07e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.21e-06	5.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOB—coronary artery disease	3.21e-06	5e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.2e-06	5e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOB—coronary artery disease	3.19e-06	4.97e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—P4HB—coronary artery disease	3.19e-06	4.97e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.18e-06	4.97e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.18e-06	4.95e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.13e-06	4.88e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.12e-06	4.87e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—coronary artery disease	3.12e-06	4.86e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GGT1—coronary artery disease	3.1e-06	4.84e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GOT1—coronary artery disease	3.1e-06	4.84e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—coronary artery disease	3.1e-06	4.84e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AGT—coronary artery disease	3.09e-06	4.83e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GOT1—coronary artery disease	3.08e-06	4.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GGT1—coronary artery disease	3.08e-06	4.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—LPL—coronary artery disease	3.06e-06	4.78e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK1—coronary artery disease	3.06e-06	4.77e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—LPL—coronary artery disease	3.05e-06	4.75e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—coronary artery disease	3.03e-06	4.73e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—coronary artery disease	3.03e-06	4.73e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AGT—coronary artery disease	3.02e-06	4.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	3e-06	4.68e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOA1—coronary artery disease	3e-06	4.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.99e-06	4.66e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPX1—coronary artery disease	2.99e-06	4.66e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPX1—coronary artery disease	2.97e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—coronary artery disease	2.96e-06	4.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—coronary artery disease	2.96e-06	4.61e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—VCAN—coronary artery disease	2.95e-06	4.6e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAT—coronary artery disease	2.95e-06	4.6e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.93e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOA1—coronary artery disease	2.93e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.93e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—coronary artery disease	2.92e-06	4.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CD36—coronary artery disease	2.91e-06	4.54e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CD36—coronary artery disease	2.89e-06	4.51e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAT—coronary artery disease	2.88e-06	4.49e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPP2CA—coronary artery disease	2.87e-06	4.48e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOB—coronary artery disease	2.86e-06	4.47e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPP2CA—coronary artery disease	2.86e-06	4.46e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DCN—coronary artery disease	2.84e-06	4.43e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOB—coronary artery disease	2.79e-06	4.36e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.79e-06	4.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.79e-06	4.34e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.76e-06	4.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.76e-06	4.31e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.76e-06	4.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—coronary artery disease	2.76e-06	4.3e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.75e-06	4.29e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—coronary artery disease	2.74e-06	4.28e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.74e-06	4.27e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LPL—coronary artery disease	2.73e-06	4.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.73e-06	4.25e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—coronary artery disease	2.72e-06	4.24e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAT—coronary artery disease	2.71e-06	4.23e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LIPC—coronary artery disease	2.69e-06	4.2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HBA1—coronary artery disease	2.69e-06	4.2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.69e-06	4.2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.69e-06	4.2e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAT—coronary artery disease	2.69e-06	4.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOC3—coronary artery disease	2.68e-06	4.18e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LPL—coronary artery disease	2.67e-06	4.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPX1—coronary artery disease	2.67e-06	4.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LDLR—coronary artery disease	2.66e-06	4.15e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—coronary artery disease	2.65e-06	4.14e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—coronary artery disease	2.64e-06	4.12e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOB—coronary artery disease	2.63e-06	4.11e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.63e-06	4.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.63e-06	4.1e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AGT—coronary artery disease	2.62e-06	4.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOB—coronary artery disease	2.61e-06	4.07e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AGT—coronary artery disease	2.61e-06	4.06e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POMC—coronary artery disease	2.6e-06	4.06e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPX1—coronary artery disease	2.6e-06	4.06e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CETP—coronary artery disease	2.6e-06	4.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCLC—coronary artery disease	2.6e-06	4.05e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CD36—coronary artery disease	2.6e-06	4.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—coronary artery disease	2.58e-06	4.03e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SDC1—coronary artery disease	2.57e-06	4.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—coronary artery disease	2.57e-06	4e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.56e-06	4e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.56e-06	4e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—coronary artery disease	2.55e-06	3.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POMC—coronary artery disease	2.55e-06	3.97e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.54e-06	3.96e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOA1—coronary artery disease	2.54e-06	3.96e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CD36—coronary artery disease	2.54e-06	3.95e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOA1—coronary artery disease	2.52e-06	3.94e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LPL—coronary artery disease	2.51e-06	3.92e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.5e-06	3.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LPL—coronary artery disease	2.49e-06	3.89e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.46e-06	3.84e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPX1—coronary artery disease	2.45e-06	3.83e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPX1—coronary artery disease	2.43e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—coronary artery disease	2.43e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.43e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.43e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.43e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.42e-06	3.77e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—coronary artery disease	2.4e-06	3.75e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CD36—coronary artery disease	2.39e-06	3.73e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—coronary artery disease	2.37e-06	3.7e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CTGF—coronary artery disease	2.37e-06	3.7e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CD36—coronary artery disease	2.37e-06	3.69e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.36e-06	3.68e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.35e-06	3.67e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GOT2—coronary artery disease	2.35e-06	3.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.34e-06	3.65e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AGT—coronary artery disease	2.34e-06	3.65e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—coronary artery disease	2.32e-06	3.62e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—coronary artery disease	2.29e-06	3.57e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AGT—coronary artery disease	2.28e-06	3.56e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—coronary artery disease	2.27e-06	3.54e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOA1—coronary artery disease	2.27e-06	3.53e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.26e-06	3.53e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.24e-06	3.5e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—coronary artery disease	2.24e-06	3.49e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—coronary artery disease	2.24e-06	3.49e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—coronary artery disease	2.22e-06	3.47e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—coronary artery disease	2.22e-06	3.46e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOA1—coronary artery disease	2.21e-06	3.45e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POMC—coronary artery disease	2.21e-06	3.44e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POMC—coronary artery disease	2.19e-06	3.42e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.17e-06	3.38e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—coronary artery disease	2.17e-06	3.38e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.16e-06	3.37e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AGT—coronary artery disease	2.15e-06	3.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AGT—coronary artery disease	2.13e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—coronary artery disease	2.11e-06	3.29e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.09e-06	3.27e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—coronary artery disease	2.09e-06	3.26e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOA1—coronary artery disease	2.08e-06	3.25e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—coronary artery disease	2.08e-06	3.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOA1—coronary artery disease	2.07e-06	3.22e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.03e-06	3.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GGT1—coronary artery disease	2.03e-06	3.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GOT1—coronary artery disease	2.03e-06	3.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—coronary artery disease	2.01e-06	3.14e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—coronary artery disease	2e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.98e-06	3.08e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POMC—coronary artery disease	1.97e-06	3.07e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—coronary artery disease	1.95e-06	3.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—coronary artery disease	1.92e-06	3e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POMC—coronary artery disease	1.92e-06	3e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—coronary artery disease	1.91e-06	2.98e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—coronary artery disease	1.84e-06	2.86e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.82e-06	2.84e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—coronary artery disease	1.82e-06	2.84e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POMC—coronary artery disease	1.81e-06	2.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.81e-06	2.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.8e-06	2.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POMC—coronary artery disease	1.79e-06	2.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—coronary artery disease	1.79e-06	2.8e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAT—coronary artery disease	1.77e-06	2.77e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—coronary artery disease	1.76e-06	2.74e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—coronary artery disease	1.75e-06	2.73e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—coronary artery disease	1.75e-06	2.73e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOB—coronary artery disease	1.72e-06	2.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—coronary artery disease	1.72e-06	2.68e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—coronary artery disease	1.68e-06	2.61e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.67e-06	2.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—coronary artery disease	1.65e-06	2.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPL—coronary artery disease	1.64e-06	2.56e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—coronary artery disease	1.64e-06	2.55e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX1—coronary artery disease	1.6e-06	2.5e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—coronary artery disease	1.58e-06	2.46e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.57e-06	2.45e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—coronary artery disease	1.57e-06	2.44e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CD36—coronary artery disease	1.56e-06	2.44e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.54e-06	2.41e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—coronary artery disease	1.53e-06	2.39e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.48e-06	2.31e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.44e-06	2.25e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.43e-06	2.23e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AGT—coronary artery disease	1.41e-06	2.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—coronary artery disease	1.38e-06	2.15e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA1—coronary artery disease	1.36e-06	2.12e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1.28e-06	1.99e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.25e-06	1.95e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—coronary artery disease	1.2e-06	1.87e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POMC—coronary artery disease	1.18e-06	1.85e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.08e-06	1.69e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—coronary artery disease	1.08e-06	1.68e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—coronary artery disease	1.08e-06	1.68e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—coronary artery disease	1.04e-06	1.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—coronary artery disease	1.03e-06	1.61e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—coronary artery disease	1.02e-06	1.59e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—coronary artery disease	9.66e-07	1.51e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.44e-07	1.47e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—coronary artery disease	9.43e-07	1.47e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	8.88e-07	1.39e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—coronary artery disease	8.84e-07	1.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	8.81e-07	1.37e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—coronary artery disease	8.79e-07	1.37e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—coronary artery disease	7.89e-07	1.23e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—coronary artery disease	7.7e-07	1.2e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—coronary artery disease	7.26e-07	1.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—coronary artery disease	7.2e-07	1.12e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.81e-07	9.06e-06	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—coronary artery disease	4.75e-07	7.4e-06	CbGpPWpGaD
